Newsletter | January 23, 2024

01.23.24 -- 4 Strategies To Formulate Poorly Soluble APIs


4 Strategies To Formulate Poorly Soluble APIs

One of the toughest challenges facing small molecule drug development today is poor solubility of the API. No single technique has universal application, so several strategies exist. This article examines four notable strategies.

Animal Testing Isn’t Perfect. Is There An Alternative?

Statistics have been showing that rodent and non-rodent experiments predict human toxicity in only 48-71% of drugs. The FDA Modernization Act 2.0 of 2022 permits the use of suitable animal-free new approach methodologies, and the European Parliament launched a program to eliminate animal studies "as soon as scientifically possible." Let's take a data-driven, research-driven look at the topic.


FUST Lab's DEBREX Enters The Japanese Market

Precipio Signs Distribution Agreement For IV-Cell And HemeScreen In Japan

IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx

Epredia Announces The U.S. Launch Of SlideMate Laser

Sapio Sciences Announces Full GxP Validation Of Its Unified Lab Informatics Platform

Guardant Health To Present Data At ASCO GI Supporting Use Of Liquid Biopsy

CGI & Tribun Health Selected To Lead Digital Pathology Transformation

The Christie Pilots Blood Test To Improve Melanoma Treatment

Parse Biosciences Acquires Biomage

Cepheid Receives Expanded FDA Clearance With CLIA Waiver For Xpert Xpress MVP

Myriad Genetics To Acquire Precise Tumor, Precise Liquid & Laboratory